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Abstract 
Objectives: Our aim is to investigate socioeconomic disparities in cervical cancer screening 
utilization among and between ethnic groups in the United States. 
Study Design and Methods: Data on 27,238 women aged 21 to 64 are obtained from the 
2007 – 2011 years of the Medical Expenditure Panel Survey. Data on cervical cancer 
screening utilization in the preceding 12 months and 3 years and a range of socio-
demographic characteristics is included. Analyses are undertaken for all women and across 
racial/ethnic grouping (White, Black, Hispanic, and Other). Concentration indices are used to 
measure the socioeconomic gradient across ethnic groups. Probit regression analyses are used 
to examine variations in utilization related to socioeconomic factors across ethnic groups 
controlling for a range of pertinent characteristics. 
Results: Annual utilization rates are high in the US (60%) and greatest among Black women 
(66%). Disparities as measured by concentration indices were large in the US and are largest 
for White women (CI=0.179) relative to Black (CI=0.103) and Hispanic (CI=0.081) women. 
Screening differences across income, education and insurance status are also greater amongst 
White women. 
Conclusions: Annual utilization – too frequent utilization – of cervical cancer screening is 
high in the US with large socioeconomic disparities also evident. Those from lower 
socioeconomic or uninsured groups who are most likely to have, and to die from cervical 
cancer, are least likely to screen. Disparities differ across ethnic groups and are greatest 
amongst White women. Incorporating organized screening may serve to improve both the 
systems efficiency and address disparities between and within groups. 
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Introduction 
In the United States (US) age-standardized mortality rates for cervical cancer fell from 5.6 
deaths per 100,000 women in 1975 to 2.3 per 100,000 in 2010.1 Screening was instrumental 
in this reduction in mortality. Differences in mortality rates across socioeconomic groups2,3 
and racial/ethnic groups4,5 have also been linked to differences in screening utilization across 
these groups. Age-standardized cervical cancer mortality rates among non-Hispanic Black 
(termed Black from hereon) and Hispanic women were 4.2 per 100,000 individuals and 2.9 
per 100,000 individuals respectively compared to 2.2 per 100,000 individuals among non-
Hispanic White (termed White from hereon) women.1 While disparities across ethnic groups 
in cervical cancer treatment may explain some of the differences in mortality6, lower 
screening rates among non-White women in the past may also explain these mortality 
differences. 
 
Examining screening disparities between groups can aid in understanding the nature of 
barriers to screening and in developing appropriate policy responses. Despite the fact that 
evidence shows that cervical screening utilization differs between ethnic groups and 
socioeconomic groups in the US,7-10 there is a dearth of research examining how 
socioeconomic disparities may differ across ethnicities. There is evidence that higher income 
and private health insurance are predictors of screening for White and Hispanic women, but 
they play a small (insignificant) role for Black women.7 Income and education disparities 
have also been shown to be greater among White women relative to other groups.11 However, 
more detailed analyses of these relationships are not pursued in these studies, in part perhaps 
because of limitations in the data used with respect to a fuller range of socio-demographic 
variables. Similarly, no attempt is made to quantify or compare socioeconomic disparities 
between groups to inform discussion of relationships. If differences in socioeconomic 
disparities between ethnicities exist, this would add to our understanding and prompt more 
effectively tailored policy instruments. In this paper, we augment an analysis using regression 
techniques with an examination of the socioeconomic gradient in cervical cancer screening 
using concentration indices to shed further light on the issue of disparities.  
 
Methods 
Data  
Data from the 2007 – 2011 years of the Medical Expenditure Panel Survey (MEPS) are used 
in the analysis. MEPS is a nationally representative survey of respondents’ health, health care 
usage and a range of socio-demographic characteristics. Years 2007 – 2011 are chosen in 
order to increase the number of observations available. Years prior to 2007 are not included 
as they do not incorporate the same explanatory variable relating to total household income, 
and 2011 corresponds to the most recent year available. In the MEPS survey design, 
individuals are included in two consecutive waves of the survey. To prevent double counting 
in our pooled sample, only individuals in their second wave are included. 
 
Within MEPS, women are asked if they screened for cervical cancer i) in the past year, ii) 
within the past 2 years, iii) within the past 3 years, iv) within the past 5 years, v) more than 5 
years, vi) never screened. Using this variable, screening in the preceding 12 months and 3 
years are analyzed amongst women aged 21 to 64 producing 27,238 observations. 12,282 
were categorized as White, 5,451 as Black, 7,248 as Hispanic and 2,257 as Other ethnicities 
(including Asian and native American women, native Hawaiian/Pacific islander and multiple 
races). This age-group is recommended for screening by the American Cancer Society (ACS) 
and US Preventive Services Task Force (USPSTF).12,13 Survey weights based upon the 
probability of being sampled in the survey are used to facilitate the robust extrapolation of 
results to the overall population. We examine utilization at 12 months and 3 years to ascertain 
the stability of observed relationships at different intervals. Furthermore, while the USPSTF 
and ACS recommend screening using Pap tests every three years for women aged 21 to 64, 
annual screening is commonplace in the US.14 Under the Affordable Care Act 26 States 
mandate annual screening for privately insured women.15 
 
Concentration Indices 
Socioeconomic disparities are calculated using concentration indices (CI). The CI allows us 
to measure the extent to which screening utilization in different income groups reflects their 
proportionate representation in the population. CIs are one of the foremost methods for 
calculating and comparing socioeconomic disparities,16 including for cervical cancer 
screening17,18 and other forms of screening.19 
 
A continuous measure of socioeconomic status allows for the most precise calculation of 
CIs.20 The total household income variable (FAMINC) in MEPS provides the measure of 
socioeconomic status in our analysis. Using this variable offers greater comparability among 
women in paid employment and those who are home makers for instance. Income is further 
equivalised to allow for more meaningful comparisons between women with different size 
households where disposable income might vary.i The OECD equivalence scale (square root 
of the number of people in the household) is chosen. It is this equivalised income variable 
which is thus used to rank women from the poorest to the richest in the sample. 
 
The CI calculates a disparity estimate between -1 (screening disproportionately higher among 
poor) and +1 (screening disproportionately higher among rich), with 0 representing an equal 
                                                 
i
 In our sample family size for White, Black, Hispanic and Other is 2.76, 2.98, 3.91 and 3.33 members per 
household respectively. 
distribution of screening across the ranking variable. The CI can be expressed as twice the 
covariance between screening ( ) and income ( ) divided by the mean of screening ( ̅): 
        ሺ  ሻ ̅  
For binary variables (whether woman screened in preceding 12 months or 3 years) the CI 
above is no longer bounded between -1 and +1. Therefore, it is further divided by 1 minus  ̅ 
to allow for the inequality to be measured between -1 and +1. This is known as the Wagstaff 
correction.21 The CI used our analysis is thus expressed as: 
 
       ሺ  ሻ ̅    ̅⁄ . 
 
Regression Analyses 
Probit regression analyses were also undertaken allowing for adjusted socioeconomic 
disparities to be calculated, controlling for other potential confounders, and allowing for 
differences across education, marital status and health insurance status to be measured. 
Results are presented as marginal effects with standard errors clustered at the region level.ii 
Explanatory variables included were: educational attainment (Degree or higher, high school 
degree, and less than high school); marital status (married/cohabiting or not), age (5 year age-
groups), geographic regions (Northeast, Midwest, South, and West) and ethnicity (White, 
Black, Hispanic, and Other). While the insurance plan of the woman was available, for ease 
of comparison health insurance status is included as any private insurance, only public 
insurance, and uninsured. While continuous equivalised household income is used to 
                                                 
ii
 While Odds Ratios allow for greater ease of interpretation, they cannot accurately be compared across models 
or across groups within a model.22, 23 Therefore marginal effects are calculated in this study. 
calculate the CIs, to allow for ease of interpretation of income it is partitioned into quintiles 
in the regression. 
 
Results 
Table 1 presents the descriptive statistics for the study sample. Whites constitute 45.09% of 
the sample, 20.01% are Black, 26.61% are Hispanic and 8.29% are Other. 32.49% had at 
least a Degree, 52.6% were married or cohabiting, 61.11% had private health insurance and 
21% were uninsured. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Descriptive Statistics 
 Mean Observations 
Overall 100% 27,238 
Ethnicity   
White 45.09% 12,282 
Black 20.01% 5,451 
Hispanic 26.61% 7,248 
Other 8.29% 2,257 
Income Quintile   
Income 1 (Lowest) 22.77% 6,203 
Income 2 19.82% 5,399 
Income 3 19.30% 5,257 
Income 4 19.46% 5,300 
Income 5 (Highest) 18.65% 5,079 
Education   
Degree or higher 32.49% 8,852 
High school 45.30% 12,340 
Less than high school 22.20% 6,048 
Marital Status   
Married/Cohabitating 52.60% 14,326 
Unmarried 47.40% 12,912 
Insurance Status   
Private Insurance 61.11% 16,644 
Public Insurance 17.89% 4,874 
Uninsured 21.00% 5,720 
Age Group   
Age 21-24 10.76% 2,930 
Age 25-29 11.35% 3,091 
Age 30-34 11.73% 3,196 
Age 35-39 11.70% 3,187 
Age 40-44 11.78% 3,208 
Age 45-49 12.12% 3,300 
Age 50-54 11.61% 3,163 
Age 55-59 10.46% 2,848 
Age 60-65 8.50% 2,315 
Region   
Northeast 15.16% 4,130 
Midwest 19.98% 5,443 
South 38.69% 10,538 
West 26.17% 7,127 
 
 
 
 
 
Table 2 presents utilization rates for cervical cancer screening in the preceding 12 months and 
3 years with results partitioned across ethnicities. In the 12 month period, utilization in the 
US was 59.59%. Black women had higher utilization (66.05%) than Whites (60.05%) and 
Hispanics (57.97%). Utilization was higher amongst those in the highest income quintile 
compared to those in the poorest income quintile (67.93% versus 53.28%). Although an 
income gradient exists for each groups, the differential between the richest and poorest 
women was larger for Whites (68.12% versus 49.54%) than for Blacks (75.12% versus 
61.73%) and Hispanics (70.14% versus 54.56%). Disparities are also greater for White 
women across to education and insurance status. Lower educated Blacks (58.14%) and 
Hispanics (54.12%) had greater 12 month utilization than similar Whites (43.55%). Blacks 
with private health insurance (71.36%) had higher utilization than Whites (64.66%) and 
Hispanics (63.71%) with private health insurance. Uninsured White women had far lower 
utilization (34.14%) than uninsured Black (43.52%) and Hispanic (47.51%) women. 
Screening utilization across Regions also differed across ethnicities though utilization for 
each group is greatest in the Northeast.  
 
Overall utilization in the preceding 3 years in the US is 85.51%. Utilization is greater for 
Black (89.95%) than Hispanic (85.84%) and White (85.26%) women. While White, Black 
and Hispanic women in the richest group have similar utilization, the poorest Black (88%) 
and Hispanic (84.35%) have higher utilization than the poorest White (76.92%) women. 
Once more, lower educated Black (85.98%) and Hispanic(84.20%) women and uninsured 
Black (78.87%) and Hispanic (78.30%) women have greater utilization than similar White 
women (71.50% no high school degree, 66.77% uninsured). Marital status for Hispanic and 
Other ethnic women increases utilization by 11.7 and 14.74 percentage points respectively, 
though marital status is not as important for Black and White women. 
Table2: Percentage Utilization of Cervical Cancer Screening in the US (Partitioned by Ethnicity) in the Preceding 12 months 
Observations 
US 
N=27,238 
White 
N=12,282 
Black 
N=5,451 
Hispanic 
N=7,248 
Other 
N=2,257 
US 
N=27,238 
White 
N=12,282 
Black 
N=5,451 
Hispanic 
N=7,248 
Other 
N=2,257 
Overall 59.95% 60.05% 66.05% 57.97% 52.16% 85.51% 85.26% 89.95% 85.84% 79.13% 
Income Quintile           
Income 1(Lowest) 53.28 49.54 61.73 54.56 46.19 81.03 76.92 88.00 84.35 75.83 
Income 2 51.56 48.15 62.25 55.35 40.19 80.15 77.95 86.61 83.93 69.31 
Income 3 57.54 56.24 67.84 57.96 48.84 84.42 83.10 91.90 85.84 79.02 
Income 4 62.69 63.26 69.32 58.27 54.01 87.56 87.99 91.68 86.95 77.92 
Income 5 (Highest) 67.93 68.12 73.12 70.14 60.44 90.08 90.15 93.54 91.24 85.60 
Education           
Degree or higher 66.96 67.59 72.25 63.60 58.82 90.69 90.98 93.91 90.55 84.85 
High school degree 56.70 55.51 64.83 58.22 46.01 82.93 82.04 88.84 84.76 73.60 
No high school degree 49.48 43.35 58.14 54.12 42.62 78.36 71.50 85.98 84.20 71.76 
Marital Status           
Married/Cohabitating 62.22 62.29 69.00 61.52 56.29 88.27 87.55 93.29 90.91 85.15 
Unmarried 57.02 56.58 64.65 53.53 46.18 81.95 81.72 88.36 79.53 70.41 
Insurance Status           
Private Insurance 64.63 64.66 71.36 63.71 55.87 88.89 88.78 92.89 90.00 82.61 
Public Insurance 57.32 50.56 68.16 61.23 51.19 82.68 76.55 90.13 88.17 80.82 
Uninsured 39.51 34.14 43.52 47.51 32.33 71.51 66.77 78.87 78.30 58.10 
Age Group           
Age 21-24 58.57 61.68 73.58 61.17 57.32 91.40 84.53 86.13 71.23 57.99 
Age 25-29 67.61 69.47 68.11 48.76 40.68 80.26 92.94 94.37 88.27 81.10 
Age 30-34 67.11 67.65 72.90 64.59 59.90 93.42 92.90 96.59 94.20 90.32 
Age 35-39 63.14 64.40 69.93 58.83 53.36 90.20 90.23 93.42 90.09 85.36 
Age 40-44 61.91 60.62 72.32 62.52 53.57 88.29 88.07 94.19 87.92 80.56 
Age 45-49 58.11 57.54 64.85 56.89 54.27 84.95 83.33 90.47 87.21 86.70 
Age 50-54 55.93 55.36 58.99 57.63 53.60 82.36 82.16 86.50 82.93 75.27 
Age 55-59 54.79 55.32 55.64 54.74 46.53 79.97 78.67 83.23 85.65 80.57 
Age 60-65 51.29 51.92 51.53 48.83 45.19 77.54 77.56 80.38 79.40 68.86 
Region           
Northeast 63.73 63.79 68.89 63.32 56.35 88.91 87.75 91.59 88.22 85.88 
Midwest 60.01 59.60 66.95 60.65 51.52 85.00 84.39 91.92 87.44 77.80 
South 59.88 60.31 65.75 52.94 51.21 85.21 85.00 89.12 83.63 76.60 
West 57.04 56.65 60.86 60.12 50.95 84.46 84.52 88.52 86.70 77.92 
Figure 1 presents CIs for screening in the preceding 12 months and 3 years partitioned by 
ethnic group. In the US, and across all groups, pro-rich patterns (screening disproportionately 
higher among rich) exist. In the US, CI=0.144*** and CI=0.174*** are observed at 12 
months and 3 years respectively. There are marked differences across ethnic groups. The 
largest disparities are observed amongst White women for the 12 month (CI=0.179***) and 3 
year (CI=0.224***) periods. However, significant disparities exist for Blacks (CI=0.103*** 
12 months; CI=0.151*** 3 years), Hispanics (CI=0.081*** 12 months; CI=0.079*** 3 years) 
and Other (CI=0.159*** 12 months; CI=0.178*** 3 years). 
 
Figure 1:  Concentration Indices for Cervical Cancer Screening in Previous 12 months 
and 3 Years. 95% Confidence Intervals 
 
 
Table 2, illustrates the marginal effects following a probit regression of cervical cancer 
screening in the US. Utilization for Black and Hispanic women is 10.4 and 5.6 percentage 
points higher compared to White women, ceteris paribus, and is lower for Other ethnicity 
(ME= -0.088***). Income disparities are greatest for Whites confirming the results of the CIs 
and women with lowest income have a ME= -0.087*** compared to the richest White 
women. In the US, compared to those with a degree, lower utilization is seen for the lowest 
education group (ME= -0.100***) with differences greatest for White women (ME= -
0.149***). Being married is correlated strongly with screening for Hispanic women (ME= 
0.067***). However the largest disparities are observed across insurance status. In the US 
sample, uninsured women’s probability of screening is far lower than women with private 
insurance (ME= -0.221***) with the difference between across insurance status greatest for 
White (ME= -0.255***) and Black (ME= -0.253***) women, double that of Hispanic women 
(ME= -0.136***). No difference in the probability is seen between private and public health 
insurance for Hispanic women, though differences are observed with the White and Black 
groups. For White and Black women living in the West reduces the probability of screening 
by the greatest amount (ME= -0.62***; ME= -0.092***) while for Hispanic women the 
lowest utilization is in the South (ME= -0.88***). 
 
Within the 3 year period some differences with the 12 month results are observed. Blacks 
(ME= 0.069***) and Hispanics (ME= 0.042***) have a greater probability of screening 
compared to Whites with Other ethnicity again the least likely to screen. While income 
disparities exist in the US as a whole and for White women, little or no income disparities in 
screening utilization are observed for Black and Hispanic women and for women from Other 
ethnicities for the 3 year period. However, significant disparities are still observed across 
education with the lowest educated group having a lower probability of screening in the US 
(ME= -0.079***), amongst Whites (ME= -0.123***) and Blacks (ME= -0.046) but not 
amongst Hispanics. The largest disparities are observed across insurance status with these 
disparities once more greatest for Whites (ME= -0.172*** no high school degree) relative to 
Blacks (ME= -0.117*** no high school degree) and Hispanics (ME= -0.108*** no high 
school degree). Interestingly while White women with public insurance have a 6 percentage 
point lower probability of screening compared to private insurance, no differences across 
private and public insurance are observed for the other ethnic groups. Screening was highest 
in the Northeast, though the difference between regions was lower compared to the 12 month 
period. 
 
 
 
 
Table 2: Marginal Effects Following a Probit Regression Cervical Cancer Screening Utilization in the Preceding 12 months in the US 
 12 Months 3 Years 
 US White Black Hispanic Other US White Black Hispanic Other 
Income Quintiles           
Income 1 (Lowest) -0.079*** 
(0.026) 
-0.087*** 
(0.029) 
-0.048*** 
(0.016) 
-0.079* 
(0.042) 
-0.050* 
(0.026) 
-0.024 
(0.017) 
-0.039** 
(0.019) 
-0.001 
(0.013) 
0.003 
(0.022) 
0.006 
(0.035) 
Income 2 -0.112*** 
(0.024) 
-0.132*** 
(0.025) 
-0.054 
(0.013) 
-0.089*** 
(0.033) 
-0.137*** 
(0.049) 
-0.050*** 
(0.015) 
-0.059*** 
(0.019) 
-0.024 
(0.018) 
-0.021** 
(0.011) 
-0.071*** 
(0.024) 
Income 3 -0.088*** 
(0.022) 
-0.094*** 
(0.022) 
-0.038 
(0.049) 
-0.085*** 
(0.026) 
-0.077** 
(0.033) 
-0.042** 
(0.018) 
-0.051*** 
(0.018) 
0.001 
(0.011) 
-0.020 
(0.014) 
-0.024 
(0.033) 
Income 4 -0.055*** 
(0.016) 
-0.047*** 
(0.016) 
-0.041 
(0.029) 
-0.104*** 
(0.020) 
-0.049 
(0.042) 
-0.025** 
(0.011) 
-0.018 
(0.016) 
-0.015 
(0.019) 
-0.033*** 
(0.003) 
-0.062** 
(0.027) 
Income 5 (Highest) Base Base Base Base Base Base Base Base Base Base 
Education           
Degree or higher Base Base Base Base Base Base Base Base Base Base 
High school degree -0.067*** 
(0.013) 
-0.077*** 
(0.020) 
-0.046*** 
(0.011) 
-0.010 
(0.024) 
-0.066** 
(0.032) 
-0.051*** 
(0.007) 
-0.059*** 
(0.010) 
-0.029** 
(0.011) 
-0.021 
(0.022) 
-0.035 
(0.031) 
No high school 
degree 
-0.100*** 
(0.023) 
-0.149*** 
(0.030) 
-0.090*** 
(0.022) 
-0.034* 
(0.018) 
-0.103 
(0.071) 
-0.079*** 
(0.016) 
-0.123*** 
(0.016) 
-0.046*** 
(0.007) 
-0.030 
(0.020) 
-0.086 
(0.065) 
Marital Status           
Married or 
cohabitating 
0.035*** 
(0.006) 
0.024* 
(0.013) 
0.028** 
(0.013) 
0.067*** 
(0.025) 
0.056* 
(0.029) 
0.048*** 
(0.009) 
0.033*** 
(0.005) 
0.037*** 
(0.009) 
0.089*** 
(0.013) 
0.091*** 
(0.029) 
Unmarried Base Base Base Base Base Base Base Base Base Base 
Insurance Status           
Private Insurance Base Base Base Base Base Base Base Base Base Base 
Public Insurance -0.028** 
(0.011) 
-0.054*** 
(0.020) 
0.002 
(0.024) 
-0.001 
(0.025) 
0.050* 
(0.028) 
-0.036*** 
(0.008) 
-0.060*** 
(0.013) 
-0.011 
(0.011) 
-0.002 
(0.024) 
0.036 
(0.022) 
Uninsured -0.221*** 
(0.014) 
-0.255*** 
(0.018) 
-0.253*** 
(0.004) 
-0.136*** 
(0.018) 
-0.175*** 
(0.016) 
-0.153*** 
(0.005) 
-0.172*** 
(0.005) 
-0.117*** 
(0.007) 
-0.108*** 
(0.015) 
-0.086 
(0.065) 
Age Group           
Age 21-24 Base Base Base Base Base Base Base Base Base Base 
Age 25-29 0.055*** 
(0.014) 
0.035*** 
(0.012) 
0.032 
(0.027) 
0.106*** 
(0.038) 
0.111** 
(0.042) 
0.066*** 
(0.007) 
0.055*** 
(0.015) 
0.049*** 
(0.011) 
0.087** 
(0.010) 
0.116*** 
(0.019) 
Age 30-34 0.033 
(0.030) 
-0.009 
(0.031) 
0.014 
(0.042) 
0.137*** 
(0.014) 
0.105*** 
(0.027) 
0.078*** 
(0.006) 
0.045*** 
(0.013) 
0.067*** 
(0.003) 
0.121*** 
(0.003) 
0.162*** 
(0.021) 
Age 35-39 -0.010 
(0.023) 
-0.042* 
(0.024) 
-0.023 
(0.025) 
0.072*** 
(0.015) 
0.055** 
(0.025) 
0.046** 
(0.017) 
0.014 
(0.024) 
0.035*** 
(0.010) 
0.088*** 
(0.006) 
0.129*** 
(0.017) 
Age 40-44 -0.029 
(0.030) 
-0.088*** 
(0.033) 
0.001 
(0.037) 
0.104*** 
(0.025) 
0.056*** 
(0.019) 
0.025 
(0.024) 
-0.014 
(0.034) 
0.042*** 
(0.006) 
0.072*** 
(0.006) 
0.095* 
(0.042) 
Age 45-49 -0.066** 
(0.032) 
-0.116*** 
(0.032) 
-0.066 
(0.048) 
0.043* 
(0.024) 
0.085* 
(0.047) 
-0.003 
(0.026) 
-0.063** 
(0.033) 
0.014 
(0.018) 
0.067*** 
(0.008) 
0.152** 
(0.039) 
Age 50-54 -0.100** 
(0.051) 
-0.151*** 
(0.051) 
-0.134*** 
(0.030) 
0.048 
(0.030) 
0.075* 
(0.040) 
-0.036 
(0.035) 
-0.088** 
(0.046) 
-0.021 
(0.021) 
0.038*** 
(0.011) 
0.073* 
(0.033) 
Age 55-59 -0.111*** 
(0.035) 
-0.152*** 
(0.031) 
-0.168*** 
(0.044) 
0.028* 
(0.016) 
0.001 
(0.061) 
-0.058* 
(0.034) 
-0.125*** 
(0.032) 
-0.050* 
(0.032) 
0.060*** 
(0.005) 
0.100*** 
(0.031) 
Age 60-65 -0.144*** 
(0.032) 
-0.184*** 
(0.028) 
-0.202*** 
(0.033) 
-0.029 
(0.025) 
-0.009 
(0.025) 
-0.079*** 
(0.032) 
-0.137*** 
(0.031) 
-0.062*** 
(0.022) 
0.021 
(0.026) 
0.028 
(0.069) 
Region           
Northeast Base Base Base Base Base Base Base Base Base Base 
Midwest -0.029*** 
(0.001) 
-0.028*** 
(0.007) 
-0.016*** 
(0.001) 
-0.037*** 
(0.006) 
-0.021*** 
(0.003) 
-0.025*** 
(0.001) 
-0.022*** 
(0.002) 
0.008*** 
(0.002) 
-0.036*** 
(0.006) 
-0.073*** 
(0.007) 
South -0.022*** 
(0.004) 
-0.010*** 
(0.003) 
-0.015*** 
(0.004) 
-0.088*** 
(0.009) 
-0.003 
(0.004) 
-0.021*** 
(0.002) 
-0.011*** 
(0.002) 
-0.018*** 
(0.003) 
-0.012*** 
(0.003) 
-0.056*** 
(0.007) 
West -0.048*** 
(0.006) 
-0.062*** 
(0.002) 
-0.092*** 
(0.002) 
-0.025*** 
(0.005) 
-0.036*** 
(0.006) 
-0.024*** 
(0.002) 
-0.025*** 
(0.000) 
-0.033*** 
(0.002) 
-0.012*** 
(0.003) 
-0.072*** 
(0.007) 
Ethnicity           
White Base - - - - Base - - - - 
Black 0.104*** 
(0.006) 
- - - - 0.069*** 
(0.005) 
- - - - 
Hispanic 0.059*** 
(0.026) 
- - - - 0.042*** 
(0.009) 
- - - - 
Other 
 
-0.088*** 
(0.009) 
- - - - -0.070*** 
(0.007) 
- - - - 
Robust standard errors in parenthesis  
* 90% statistical significance; ** 95% statistical significance; *** 99% statistical significance 
Conclusions 
This study finds evidence of significant disparities in cervical cancer screening utilization 
across socioeconomic groups in the US, supporting the findings of previous studies. 
Interestingly these disparities, as measured by Concentration Indices, are larger than those 
observed in many other countries.17, 18 Ceteris paribus, the probability of screening is higher 
among Black and Hispanic which also supports the findings of previous studies.3,8,10 
Furthermore, this study adds to the small body of literature which has examined within and 
between group differences related to ethnicity and socioeconomic status.  
 
This study finds that women with high income (as measured by CIs and regression analyses), 
a college degree or private health insurance have the largest probability to screen, and the 
probability of women screening in each of these high socioeconomic groups differs little 
regardless if they are White, Black or Hispanic (some differences are observed with Other 
ethnicities). However, among lower socioeconomic women, those in lower income groups, 
who are uninsured or have low educational attainment, utilization rates are higher for Blacks 
and Hispanics than for White women. Only by portioning the analysis across ethnic groups 
rather than analyzing the US as one entity has this novel result become known. Age-adjusted 
5 year survival for low socioeconomic (measured by area level poverty rates) Black women 
were 65.2% versus 70% for White and 81% for Hispanic women.24 Interestingly, the largest 
difference between the most and least deprived (9.2 percentage points) was observed among 
White women.24 Therefore, as lower socioeconomic women Black women currently have a 
greater probability of acquiring and dying from cervical cancer than poorer White and 
Hispanic women, risk perception may in part explain their decision to screen, though it is 
unlikely to explain all of the differences observed in our results. 
 
While screening utilization at 12 months and 3 years is high in the US by international 
standards 17,25,26,27; this conceals large socioeconomic disparities. The high utilization 
amongst socioeconomically advantaged women and/or those with private health insurance 
also demonstrate that too frequent screening may be taking place, despite recommendations 
not to do so. 3,12,14,28 This may be largely due to how screening is delivered and the large 
incentive for some practitioners to offer annual screening. While the USPSTF and the 
American Cancer Society both recommended Pap smears every three years, 92% of 
obstetricians and gynecologists’ stated that they recommend annual screening to women29 
and as noted above, the Affordable Care Act mandates this in many states for insured women. 
It follows that issues of both over screening and under screening are evident in the United 
States.  
 
While the nature of the health care system, and the importance of insurance in acquiring a 
screen, may underlie much of the disparities observed in this study, the lack of an organized 
screening program is also likely to be a significant factor. Organized population-based 
screening such as in Europe has been shown to reduce socioeconomic disparities in cervical 
cancer screening.30,31 Additionally, organized programs are more cost-effective. For example, 
the US has four times as many cervical cancer screens as the organized Netherlands screening 
program, but the extra screens have not lead to improved mortality rates.32 Using a timely 
screening interval, such as every 3 years rather than annual screening, would result in 
estimated savings of $404 million in the US.33 Reducing too frequent screening would 
additionally reduce unnecessary non-pecuniary costs and psychological harms for over 
screened women associated with false positives. Policy should be focused not on facilitating 
the too frequent screening of some groups, but on encouraging screening among women who 
never or rarely screen.34 It is the low utilization women that make up the majority of all 
cervical cancer deaths in the US, and most of these women are in the lowest socioeconomic 
groups.35 Organized screening programs could more accurately include these poorer, under-
screened women. An organized program may also help reduce screening for women with 
short life expectancies, many of whom screen at a high rate with little chance of the screen 
reducing the probability of dying from cervical cancer.36 
 
Cancer researchers and policy advocates in the US have increasingly acknowledged that 
organized screening is superior to the opportunistic approach currently in place.37, 38 A key 
element of organized programs, invitations to screen, can be tailored to individual risk, at 
timely intervals and would aid screening low utilization (poorer) groups, while reducing too 
frequent screening in other groups.38,39,40 An organized program may additionally serve to 
reduce any stigma that might be associated with cervical cancer screening that might serve to 
deter utilization across groups. As the effectiveness of early diagnosis is contingent upon 
early access to treatment, any organized programs should also strive to offer quick access to 
treatment to women regardless of insurance status. 
 
As these results find that uninsured women have utilization rates much lower than their 
publicly or privately insured counterparts, the expansion of Medicaid under the Affordable 
Care Act is likely to reduce the number of women under screening. Our results suggest that 
this may be especially true case for Black and Hispanic women where no difference in 
screening is observed across publicly and privately insured women. The failure of half of the 
states to expand Medicaid following the Affordable Care Act is likely to be a significant 
barrier in reducing disparities observed in this study and increase screening for those poorer 
women who need this screen the most. 
Owing to the lower screening rates and higher incidence and death rates among Black and 
Hispanic, the greater utilization is to be welcomed, though over screening among more 
affluent Black and Hispanics is still a concern. However, improving utilization to poorer 
Black and Hispanics should be the focus of policy women. Disparities in screening are 
greatest for Whites and screening rates for poorer Whites are far lower than their Black and 
Hispanic counterparts. But it is clear from these results that interventions are needed to 
improve screening among poorer White women. A system of organized cancer screening may 
simultaneously serve to improve efficiency and reduce disparities in screening. But due to the 
differences in screening behavior both across ethnic and socioeconomic groups, a multi-
faceted policy, with a strong focus on poor White women, is needed to achieve parity in 
screening utilization the US. 
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